BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15352642)

  • 1. Pilot evaluation of citalopram for the relief of hot flashes.
    Barton DL; Loprinzi CL; Novotny P; Shanafelt T; Sloan J; Wahner-Roedler D; Rummans TA; Christensen B; Dakhill SR; Martin LS
    J Support Oncol; 2003; 1(1):47-51. PubMed ID: 15352642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine.
    Loprinzi CL; Flynn PJ; Carpenter LA; Atherton P; Barton DL; Shanafelt TD; Rummans TA; Sloan JA; Adjei AA; Mincey BA; Fitch TR; Collins M
    J Palliat Med; 2005 Oct; 8(5):924-30. PubMed ID: 16238505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.
    Freeman EW; Guthrie KA; Caan B; Sternfeld B; Cohen LS; Joffe H; Carpenter JS; Anderson GL; Larson JC; Ensrud KE; Reed SD; Newton KM; Sherman S; Sammel MD; LaCroix AZ
    JAMA; 2011 Jan; 305(3):267-74. PubMed ID: 21245182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors.
    Stearns V; Isaacs C; Rowland J; Crawford J; Ellis MJ; Kramer R; Lawrence W; Hanfelt JJ; Hayes DF
    Ann Oncol; 2000 Jan; 11(1):17-22. PubMed ID: 10690382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9.
    Barton DL; LaVasseur BI; Sloan JA; Stawis AN; Flynn KA; Dyar M; Johnson DB; Atherton PJ; Diekmann B; Loprinzi CL
    J Clin Oncol; 2010 Jul; 28(20):3278-83. PubMed ID: 20498389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of citalopram and venlafaxine's role in treating sleep disturbances in menopausal women, a randomized, double-blind, placebo-controlled trial.
    Davari-Tanha F; Soleymani-Farsani M; Asadi M; Shariat M; Shirazi M; Hadizadeh H
    Arch Gynecol Obstet; 2016 May; 293(5):1007-13. PubMed ID: 26437957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and Comparison of Citalopram and Venlafaxine for Management of Hot Flashes in Women with Breast Cancer.
    Taleghani SY; Etesam F; Esfandbod M
    Drug Res (Stuttg); 2023 Oct; 73(8):465-472. PubMed ID: 37647930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of citalopram on climacteric symptoms.
    Kalay AE; Demir B; Haberal A; Kalay M; Kandemir O
    Menopause; 2007; 14(2):223-9. PubMed ID: 17224858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escitalopram reduces hot flashes in nondepressed menopausal women: A pilot study.
    Defronzo Dobkin R; Menza M; Allen LA; Marin H; Bienfait KL; Tiu J; Howarth J
    Ann Clin Psychiatry; 2009; 21(2):70-6. PubMed ID: 19439155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of escitalopram on hot flash interference: a randomized, controlled trial.
    Carpenter JS; Guthrie KA; Larson JC; Freeman EW; Joffe H; Reed SD; Ensrud KE; LaCroix AZ
    Fertil Steril; 2012 Jun; 97(6):1399-404.e1. PubMed ID: 22480818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antidepressant citalopram cuts hot flash severity and frequency.
    Harv Womens Health Watch; 2010 Sep; 18(1):6-7. PubMed ID: 20960703
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of a combination of Nigella sativa and Vitex agnus-castus with citalopram on healthy menopausal women with hot flashes: results from a subpopulation analysis.
    Molaie M; Darvishi B; Jafari Azar Z; Shirazi M; Amin G; Afshar S
    Gynecol Endocrinol; 2019 Jan; 35(1):58-61. PubMed ID: 30129806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer.
    Weitzner MA; Moncello J; Jacobsen PB; Minton S
    J Pain Symptom Manage; 2002 Apr; 23(4):337-45. PubMed ID: 11997203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.
    Boekhout AH; Vincent AD; Dalesio OB; van den Bosch J; Foekema-Töns JH; Adriaansz S; Sprangers S; Nuijen B; Beijnen JH; Schellens JH
    J Clin Oncol; 2011 Oct; 29(29):3862-8. PubMed ID: 21911720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New generation nonhormonal management for hot flashes.
    Imai A; Matsunami K; Takagi H; Ichigo S
    Gynecol Endocrinol; 2013 Jan; 29(1):63-6. PubMed ID: 22809093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.
    Loprinzi CL; Levitt R; Barton D; Sloan JA; Dakhil SR; Nikcevich DA; Bearden JD; Mailliard JA; Tschetter LK; Fitch TR; Kugler JW
    J Clin Oncol; 2006 Mar; 24(9):1409-14. PubMed ID: 16505409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of escitalopram on insomnia symptoms and subjective sleep quality in healthy perimenopausal and postmenopausal women with hot flashes: a randomized controlled trial.
    Ensrud KE; Joffe H; Guthrie KA; Larson JC; Reed SD; Newton KM; Sternfeld B; Lacroix AZ; Landis CA; Woods NF; Freeman EW
    Menopause; 2012 Aug; 19(8):848-55. PubMed ID: 22433978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors.
    Loprinzi CL; Pisansky TM; Fonseca R; Sloan JA; Zahasky KM; Quella SK; Novotny PJ; Rummans TA; Dumesic DA; Perez EA
    J Clin Oncol; 1998 Jul; 16(7):2377-81. PubMed ID: 9667254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women.
    Stubbs C; Mattingly L; Crawford SA; Wickersham EA; Brockhaus JL; McCarthy LH
    J Okla State Med Assoc; 2017 May; 110(5):272-274. PubMed ID: 28649145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapse of vasomotor symptoms after discontinuation of the selective serotonin reuptake inhibitor escitalopram: results from the menopause strategies: finding lasting answers for symptoms and health research network.
    Joffe H; Guthrie KA; Larson J; Cohen LS; Carpenter JS; Lacroix AZ; Freeman EW
    Menopause; 2013 Mar; 20(3):261-8. PubMed ID: 23435022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.